✦ LIBER ✦

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

✍ Scribed by Diego Garcia-Borreguero; Ronald Grunstein; Guruswamy Sridhar; Tilman Dreykluft; Pasquale Montagna; René Dom; Eric Lainey; Anne Moorat; James Roberts

Book ID: 116884268
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 159 KB
Volume: 8
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2006.09.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term open-label study of pramipexol

Long-term open-label study of pramipexole in patients with primary restless legs syndrome

✍ Yuichi Inoue; Kenji Kuroda; Koichi Hirata; Naohisa Uchimura; Tatsuo Kagimura; Te 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Open-label study of the long-term effica

Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)

✍ Markku Partinen; Kari Hirvonen; Leni Jama; Anniina Alakuijala; Christer Hublin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Ropinirole is effective in the long-term

Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial

✍ Jacques Montplaisir; Jeff Karrasch; Jean Haan; Dieter Volc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 1 views

## Abstract The objective of this study was to investigate the long‐term efficacy of ropinirole in patients with restless legs syndrome (RLS) and to assess the potential for relapse after the discontinuation of active treatment. Patients with primary RLS (n = 202) received single‐blind ropinirole f

Long-Term Safety and Efficacy of Donepez

Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

✍ Ikeda, Manabu; Mori, Etsuro; Kosaka, Kenji; Iseki, Eizo; Hashimoto, Mamoru; Mats 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 856 KB

Long-term safety and efficacy of rotigot

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study

✍ Wolfgang Oertel; Claudia Trenkwalder; Heike Beneš; Luigi Ferini-Strambi; Birgit 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 391 KB

A 52-week open-label study of the safety

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

✍ Gopal, S.; Vijapurkar, U.; Lim, P.; Morozova, M.; Eerdekens, M.; Hough, D. 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 288 KB